Rockefeller Financial Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-4,202
Closed -$105K – 447
2017
Q1
$105K Sell
4,202
-5,735
-58% -$139K ﹤0.01% 354
2016
Q4
$215K Hold
9,937
– – ﹤0.01% 322
2016
Q3
$237K Sell
9,937
-1,003
-9% -$23.9K ﹤0.01% 298
2016
Q2
$256K Buy
+10,940
New +$237K 0.01% 304
2016
Q1
– Sell
-10,368
Closed -$191K – 615
2015
Q4
$191K Sell
10,368
-6,071
-37% -$109K ﹤0.01% 341
2015
Q3
$270K Buy
+16,439
New +$281K 0.01% 302
2014
Q3
– Sell
-275
Closed -$4K – 494
2014
Q2
$4K Buy
+275
New +$3.58K ﹤0.01% 532

Other funds holding BSX

Rockefeller Financial Services's BSX Position: Q2 2017 in Review

Rockefeller Financial Services sold out of Boston Scientific (BSX) in Q2 2017, closing a stake of 4,202 shares — an estimated $105K sold.

Rockefeller Financial Services first reported a position in BSX in Q2 2014 and held it in 7 quarters. The position peaked at $270K in Q3 2015. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

  • Rockefeller Financial Services reported no remaining Boston Scientific position as of Q2 2017 after selling out during the quarter.
  • Rockefeller Financial Services sold 4,202 Boston Scientific shares in Q2 2017, an estimated $105K.
  • Rockefeller Financial Services first reported a position in Boston Scientific in Q2 2014 and held it in 7 quarters.
  • Rockefeller Financial Services's Boston Scientific position peaked at $270K in Q3 2015.
  • 558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on Rockefeller Financial Services's 13F filing for Q2 2017, filed 18 Jul 2017.